# Janus Henderson Investors' Pharma Investments: 35 Startups in Its Portfolio (2026) > The 35 Pharma startups Janus Henderson Investors has backed, by stage: $6.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/janus-henderson-investors-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 17 - [Dianthus Therapeutics](https://millionrounds.com/company/dianthus-therapeutics) - [Vaxcyte](https://millionrounds.com/company/vaxcyte) - [Maze Therapeutics](https://millionrounds.com/company/maze-therapeutics) - [Edgewise Therapeutics](https://millionrounds.com/company/edgewise-therapeutics) - [Jade Biosciences](https://millionrounds.com/company/jade-biosciences) - [Day One Biopharmaceuticals](https://millionrounds.com/company/day-one-biopharmaceuticals) - [Bicara Therapeutics](https://millionrounds.com/company/bicara-therapeutics) - [Monopar](https://millionrounds.com/company/monopar) - [Mereo Biopharma](https://millionrounds.com/company/mereo-biopharma) - [Shattuck Labs](https://millionrounds.com/company/shattuck-labs) - [Entact Bio](https://millionrounds.com/company/entact-bio) - [Elevation Oncology](https://millionrounds.com/company/elevation-oncology) - [Equillium](https://millionrounds.com/company/equillium) - [CAMP4 Therapeutics](https://millionrounds.com/company/camp4-therapeutics) - [Ventyx Biosciences](https://millionrounds.com/company/ventyx-biosciences) - [ALX Oncology](https://millionrounds.com/company/alx-oncology) - [Palisade Bio](https://millionrounds.com/company/palisade-bio) ## Series B 8 - [Draig Therapeutics](https://millionrounds.com/company/draig-therapeutics) - [Metsera](https://millionrounds.com/company/metsera) - [Ocugen](https://millionrounds.com/company/ocugen) - [Diagonal Therapeutics](https://millionrounds.com/company/diagonal-therapeutics) - [Claris Biotherapeutics](https://millionrounds.com/company/claris-biotherapeutics) - [Curevo](https://millionrounds.com/company/curevo) - [Rain Oncology](https://millionrounds.com/company/rain-oncology) - [Attralus](https://millionrounds.com/company/attralus) ## Series C and later 7 - [OMass Therapeutics](https://millionrounds.com/company/omass-therapeutics) - [Parabilis Medicines](https://millionrounds.com/company/parabilis-medicines) - [Ovid Therapeutics](https://millionrounds.com/company/ovid-therapeutics) - [Artios Pharma](https://millionrounds.com/company/artios-pharma) - [Angitia Biopharmaceuticals](https://millionrounds.com/company/angitia-biopharmaceuticals) - [Cyteir Therapeutics](https://millionrounds.com/company/cyteir-therapeutics) - [35Pharma](https://millionrounds.com/company/35pharma) ## Series A 3 - [Korsana Biosciences](https://millionrounds.com/company/korsana-biosciences) - [Compass Therapeutics](https://millionrounds.com/company/compass-therapeutics) - [Caldera Therapeutics](https://millionrounds.com/company/caldera-therapeutics) ## Segment by segment ### Stage not reported 17 startups · $2.9B raised - [**Dianthus Therapeutics**](https://millionrounds.com/company/dianthus-therapeutics) Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach. United States $719M - [**Vaxcyte**](https://millionrounds.com/company/vaxcyte) Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. United States $633M - [**Maze Therapeutics**](https://millionrounds.com/company/maze-therapeutics) Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines. United States $300M - [**Edgewise Therapeutics**](https://millionrounds.com/company/edgewise-therapeutics) Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization. United States $200M - [**Jade Biosciences**](https://millionrounds.com/company/jade-biosciences) Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. United States $195M - [**Day One Biopharmaceuticals**](https://millionrounds.com/company/day-one-biopharmaceuticals) Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases. United States $175M - [**Bicara Therapeutics**](https://millionrounds.com/company/bicara-therapeutics) Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact. United States $150M - [**Monopar**](https://millionrounds.com/company/monopar) Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds. United States $147M ### Series B 8 startups · $1.1B raised - [**Draig Therapeutics**](https://millionrounds.com/company/draig-therapeutics) Draig Therapeutics is a clinical-stage biotechnology company based in Cardiff, Wales, focused on developing innovative neuropsychi United Kingdom $216M - [**Metsera**](https://millionrounds.com/company/metsera) Metsera operates as a clinical-stage biopharmaceutical company. United States $215M - [**Ocugen**](https://millionrounds.com/company/ocugen) Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes. United States $151M - [**Diagonal Therapeutics**](https://millionrounds.com/company/diagonal-therapeutics) Diagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe gen United States $125M - [**Claris Biotherapeutics**](https://millionrounds.com/company/claris-biotherapeutics) Claris Biotherapeutics is a late-clinical stage biotechnology company based in Jersey City, New Jersey. United States $124M - [**Curevo**](https://millionrounds.com/company/curevo) Curevo is a clinical-stage biotech firm that focuses on producing vaccines. United States $110M - [**Rain Oncology**](https://millionrounds.com/company/rain-oncology) Rain Oncology is a clinical-stage company focusing on research and development of innovative therapies for cancer patients. - $63M - [**Attralus**](https://millionrounds.com/company/attralus) Attralus is a clinical-stage biopharmaceutical company focused on developing innovative medicines and diagnostics for systemic amyloidosis. United States $56M ### Series C and later 7 startups · $1.4B raised - [**OMass Therapeutics**](https://millionrounds.com/company/omass-therapeutics) OMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule me United Kingdom $442M - [**Parabilis Medicines**](https://millionrounds.com/company/parabilis-medicines) Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines. United States $380M - [**Ovid Therapeutics**](https://millionrounds.com/company/ovid-therapeutics) Ovid Therapeutic's purpose is to solve intractable medical problems. United States $166M - [**Artios Pharma**](https://millionrounds.com/company/artios-pharma) Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies. United Kingdom $148M - [**Angitia Biopharmaceuticals**](https://millionrounds.com/company/angitia-biopharmaceuticals) Angitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, dedicated to developing innovative therapies United States $130M - [**Cyteir Therapeutics**](https://millionrounds.com/company/cyteir-therapeutics) Cyteir is developing the next generation of synthetic lethal therapies to treat cancer. United States $126M - [**35Pharma**](https://millionrounds.com/company/35pharma) 35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need. Canada $53M ### Series A 3 startups · $825M raised - [**Korsana Biosciences**](https://millionrounds.com/company/korsana-biosciences) Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s. United States $530M - [**Compass Therapeutics**](https://millionrounds.com/company/compass-therapeutics) Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases. United States $257M - [**Caldera Therapeutics**](https://millionrounds.com/company/caldera-therapeutics) Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD). United States $38M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names Janus Henderson Investors as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Janus Henderson Investors' Biotech portfolio** 89 startups · $21B](https://millionrounds.com/portfolio-maps/janus-henderson-investors-biotech-portfolio)[Portfolio map **Janus Henderson Investors portfolio map** 128 startups · $28B](https://millionrounds.com/portfolio-maps/janus-henderson-investors-portfolio-map)[Investments abroad **Janus Henderson Investors' investments in the United States** 111 startups · $23B](https://millionrounds.com/portfolio-maps/janus-henderson-investors-investments-united-states)[Co-investors **Who invests with Janus Henderson Investors** 80 co-investors](https://millionrounds.com/portfolio-maps/janus-henderson-investors-co-investors)[Sector portfolio **DST Global's AI portfolio** 30 startups · $203B](https://millionrounds.com/portfolio-maps/dst-global-ai-portfolio)[Sector portfolio **DST Global's Fintech portfolio** 23 startups · $18B](https://millionrounds.com/portfolio-maps/dst-global-fintech-portfolio) ## Raising from investors like Janus Henderson Investors? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)